Foreword

The Investigations Operations Manual(IOM) is the primary source regarding Agency policy and procedures for field investigators and inspectors. This extends to all individuals who perform field investigational activities in support of the Agency's public mission. Accordingly, it directs the conduct of all fundamental field investigational activities. Adherence to this manual is paramount to assure quality, consistency, and efficiency in field operations. The specific information in this manual is supplemented, not superseded, by other manuals and field guidance documents. Recognizing that this manual may not cover all situations or variables arising from field operations, any significant departures from IOM established procedures should have the concurrence of district management.

For 2009, the IOM contains some important changes which clarify or present new procedures.For instance, the LACF/AF Sample Schedule was revised and sample identification procedures were clarified in Chapter 4; additional FDA 483 guidance was added; OEI maintenance instructions reference FMD-130; and additional information related to food, drug, and veterinary products was incorporated in Chapter 5; and current import terminology was updated in Chapter6. Appendix C - Blood Values was completely revised.

As with each new edition of the IOM, please take time to review sections of the IOM for changes which may apply to your work.

Since December 1996, the IOM has been posted on ORA's Internet Website, Investigations Operations Manual. The entire IOM is available there, with all graphics included. Future updates to the IOM will be performed periodically during the year to this on-line version. The hard copy will be published annually. Remember, whether reviewing the "hard copy" or the "on-line' version of the IOM, the most recent version is the document of record.

We are committed to the continual improvement of the quality and usefulness of the IOM. Suggestions for the 2009 edition of the IOM or recommended changes, deletions, additions to the IOM may be sent to the Division of Field Investigations (HFC-130), 5600 Fishers Lane, Rockville, MD 20857 or via e-mail to the Director, DFI. You can also e-mail IOM@FDA.HHS.GOV. If you are recommending a change or revision, please use the IOM Change Request Form available from the web site.

Thank you for your continued hard work and dedication in protecting and promoting the health and well-being of the American people.

Michael A. Chappell, Acting Associate Commissioner for Regulatory Affairs
FDA/Office of Regulatory Affairs

NOTE: This manual is reference material for investigators and other FDA personnel. The document does not bind FDA and does not confer any rights, privileges, benefits or immunities for or on any person(s).